Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: HOMOARGININE - BLOOD , . Treffer: 19

2017

Raedle-Hurst, T; Mueller, M; Meinitzer, A; Maerz, W; Dschietzig, T Homoarginine-A prognostic indicator in adolescents and adults with complex congenital heart disease?
PLoS One. 2017; 12(9):e0184333-e0184333 Doi: 10.1371/journal.pone.0184333 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Seppälä, I; Oksala, N; Jula, A; Kangas, AJ; Soininen, P; Hutri-Kähönen, N; März, W; Meinitzer, A; Juonala, M; Kähönen, M; Raitakari, OT; Lehtimäki, T The biomarker and causal roles of homoarginine in the development of cardiometabolic diseases: an observational and Mendelian randomization analysis.
Sci Rep. 2017; 7(1):1130-1130 Doi: 10.1038/s41598-017-01274-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Alesutan, I; Feger, M; Tuffaha, R; Castor, T; Musculus, K; Buehling, SS; Heine, CL; Kuro-O, M; Pieske, B; Schmidt, K; Tomaschitz, A; Maerz, W; Pilz, S; Meinitzer, A; Voelkl, J; Lang, F Augmentation of phosphate-induced osteo-/chondrogenic transformation of vascular smooth muscle cells by homoarginine.
Cardiovasc Res. 2016; 110(3):408-418 Doi: 10.1093/cvr/cvw062 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Dellera, F; Ganzetti, GS; Froio, A; Manzini, S; Busnelli, M; Meinitzer, A; Sirtori, CR; Chiesa, G; Parolini, C L-homoarginine administration reduces neointimal hyperplasia in balloon-injured rat carotids.
Thromb Haemost. 2016; 116(2):400-402 Doi: 10.1160/TH15-10-0831 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Drechsler, C; Pihlstrøm, H; Meinitzer, A; Pilz, S; Tomaschitz, A; Abedini, S; Fellstrom, B; Jardine, AG; Wanner, C; März, W; Holdaas, H Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation Study.
Transplantation. 2015; 99(7):1470-1476 Doi: 10.1097/TP.0000000000000568 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pilz, S; Meinitzer, A; Gaksch, M; Grübler, M; Verheyen, N; Drechsler, C; Hartaigh, BÓ; Lang, F; Alesutan, I; Voelkl, J; März, W; Tomaschitz, A Homoarginine in the renal and cardiovascular systems.
Amino Acids. 2015; 47(9):1703-13 Doi: 10.1007/s00726-015-1993-2
Web of Science PubMed FullText FullText_MUG

 

Pilz, S; Putz-Bankuti, C; Meinitzer, A; März, W; Kienreich, K; Stojakovic, T; Pieber, TR; Stauber, RE Association of homoarginine and methylarginines with liver dysfunction and mortality in chronic liver disease.
Amino Acids. 2015; 47(9):1817-1826 Doi: 10.1007/s00726-015-2000-7
Web of Science PubMed FullText FullText_MUG

 

Tomaschitz, A; Verheyen, N; Gaksch, M; Meinitzer, A; Pieske, B; Kraigher-Krainer, E; Colantonio, C; März, W; Schmidt, A; Belyavskiy, E; Rus-Machan, J; van, Ballegooijen, AJ; Stiegler, C; Amrein, K; Ritz, E; Fahrleitner-Pammer, A; Pilz, S Homoarginine in patients with primary hyperparathyroidism.
Am J Med Sci. 2015; 349(4):306-11 Doi: 10.1097/MAJ.0000000000000419
Web of Science PubMed FullText FullText_MUG

 

Vogl, L; Pohlhammer, J; Meinitzer, A; Rantner, B; Stadler, M; Peric, S; Hammerer-Lercher, A; Klein-Weigel, P; Fraedrich, G; Kronenberg, F; Kollerits, B Serum concentrations of L-arginine and L-homoarginine in male patients with intermittent claudication: a cross-sectional and prospective investigation in the CAVASIC Study.
Atherosclerosis. 2015; 239(2):607-614 Doi: 10.1016/j.atherosclerosis.2015.02.019
Web of Science PubMed FullText FullText_MUG

 

2014

Pilz, S; Edelmann, F; Meinitzer, A; Gelbrich, G; Döner, U; Düngen, HD; Tomaschitz, A; Kienreich, K; Gaksch, M; Duvinage, A; Stahrenberg, R; Kunde, J; Schmidt, A; März, W; Wachter, R; Pieske, B Associations of methylarginines and homoarginine with diastolic dysfunction and cardiovascular risk factors in patients with preserved left ventricular ejection fraction.
J Card Fail. 2014; 20(12):923-30 Doi: 10.1016/j.cardfail.2014.09.004
Web of Science PubMed FullText FullText_MUG

 

Tomaschitz, A; Meinitzer, A; Pilz, S; Rus-Machan, J; Genser, B; Drechsler, C; Grammer, T; Krane, V; Ritz, E; Kleber, ME; Pieske, B; Kraigher-Krainer, E; Fahrleitner-Pammer, A; Wanner, C; Boehm, BO; März, W Homoarginine, kidney function and cardiovascular mortality risk.
Nephrol Dial Transplant. 2014; 29(3):663-671 Doi: 10.1093/ndt/gft512 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Drechsler, C; Kollerits, B; Meinitzer, A; März, W; Ritz, E; König, P; Neyer, U; Pilz, S; Wanner, C; Kronenberg, F; MMKD Study Group Homoarginine and progression of chronic kidney disease: results from the Mild to Moderate Kidney Disease Study.
PLoS One. 2013; 8(5):e63560-e63560 Doi: 10.1371/journal.pone.0063560 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kleber, ME; Seppälä, I; Pilz, S; Hoffmann, MM; Tomaschitz, A; Oksala, N; Raitoharju, E; Lyytikäinen, LP; Mäkelä, KM; Laaksonen, R; Kähönen, M; Raitakari, OT; Huang, J; Kienreich, K; Fahrleitner-Pammer, A; Drechsler, C; Krane, V; Boehm, BO; Koenig, W; Wanner, C; Lehtimäki, T; März, W; Meinitzer, A Genome-wide association study identifies 3 genomic loci significantly associated with serum levels of homoarginine: the AtheroRemo Consortium.
Circ Cardiovasc Genet. 2013; 6(5):505-513 Doi: 10.1161/CIRCGENETICS.113.000108 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pilz, S; Meinitzer, A; Tomaschitz, A; Kienreich, K; Dobnig, H; Schwarz, M; Wagner, D; Drechsler, C; Piswanger-Sölkner, C; März, W; Fahrleitner-Pammer, A Associations of homoarginine with bone metabolism and density, muscle strength and mortality: cross-sectional and prospective data from 506 female nursing home patients.
Osteoporos Int. 2013; 24(1):377-381 Doi: 10.1007/s00198-012-1950-9
Web of Science PubMed FullText FullText_MUG

 

2011

Drechsler, C; Meinitzer, A; Pilz, S; Krane, V; Tomaschitz, A; Ritz, E; März, W; Wanner, C Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients.
Eur J Heart Fail. 2011; 13(8):852-859 Doi: 10.1093/eurjhf/hfr056 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pilz, S; Meinitzer, A; Tomaschitz, A; Drechsler, C; Ritz, E; Krane, V; Wanner, C; Boehm, BO; März, W Low homoarginine concentration is a novel risk factor for heart disease.
Heart. 2011; 97(15): 1222-1227. Doi: 10.1136/hrt.2010.220731
Web of Science PubMed FullText FullText_MUG

 

Pilz, S; Tomaschitz, A; Meinitzer, A; Drechsler, C; Ritz, E; Krane, V; Wanner, C; Böhm, BO; März, W Low serum homoarginine is a novel risk factor for fatal strokes in patients undergoing coronary angiography.
Stroke. 2011; 42(4): 1132-1134. Doi: 10.1161/STROKEAHA.110.603035 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2010

März, W; Meinitzer, A; Drechsler, C; Pilz, S; Krane, V; Kleber, ME; Fischer, J; Winkelmann, BR; Böhm, BO; Ritz, E; Wanner, C Homoarginine, cardiovascular risk, and mortality.
Circulation. 2010; 122(10): 967-975. Doi: 10.1161/CIRCULATIONAHA.109.908988 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2007

Meinitzer, A; Puchinger, M; Winklhofer-Roob, BM; Rock, E; Ribalta, J; Roob, JM; Sundl, I; Halwachs-Baumann, G; März, W Reference values for plasma concentrations of asymmetrical dimethylarginine (ADMA) and other arginine metabolites in men after validation of a chromatographic method.
Clin Chim Acta. 2007; 384(1-2): 141-148. Doi: 10.1016/j.cca.2007.07.006
Web of Science PubMed FullText FullText_MUG Google Scholar

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum